The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended Novartis’ meningitis B vaccine, Bexsero, for approval for use in patients aged 2 months or older.

Italy’s health ministry banned the sale of four flu drugs for possible side-effects while Switzerland’s regulator, Swissmedic, also suspended deliveries of Novartis’ flu vaccines as a ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations ...

Swiss and French pharmaceutical companies Novartis and Sanofi are pushing for higher medicine prices in Europe. This content ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

Search for a state or federal candidate to see the donors and industries that support them.

Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced plans to spend $1 billion on a vaccine ...

European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...